Bulletin
Investor Alert

Indaptus Therapeutics Inc.

NAS: INDP

GO

Set Alerts

Market Index

Overview Profile Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders
/marketstate/country/us
Indaptus Therapeutics Inc.

After Hours

 --Quotes are delayed by 20 min

May 20, 2022, 7:53 p.m.

INDP
/zigman2/quotes/204811863/composite

$

2.40

Change

-0.35 -12.73%

Volume

Volume 5,853

Quotes are delayed by 20 min

/zigman2/quotes/204811863/composite

Previous close

$ 2.97

$ 2.75

Change

-0.22 -7.41%

Day low

Day high

$2.30

$2.85

Open

52 week low

52 week high

$2.13

$28.83

Open
Income Statement Balance Sheet Cash Flow Statement

Annual Financials for Indaptus Therapeutics Inc.

View Ratios
Fiscal year is January-December. All values USD millions. 20172018201920202021 5-year trend
Sales/Revenue -----
Cost of Goods Sold (COGS) incl. D&A 829,000859,000854,0008521,403
COGS excluding D&A -----
Depreciation & Amortization Expense 829,000859,000854,0008521,403
Depreciation 829,000859,000854,0008521,403
Amortization of Intangibles -----
Gross Income (829,000)(859,000)(854,000)(852)(1,403)
20172018201920202021 5-year trend
SG&A Expense 28.61M42.47M34.09M3.6M7.73M
Research & Development 24.3M35.4M26.66M2.66M2.52M
Other SG&A 4.32M7.07M7.43M--
Other Operating Expense -----
Unusual Expense (220,000)194,00013.65M--
EBIT after Unusual Expense 220,000(43.52M)(48.6M)--
Non Operating Income/Expense 70,000(747,000)1.32M15,11017,720
Non-Operating Interest Income 286,000852,000330,000--
Equity in Affiliates (Pretax) -----
Interest Expense 17,00023,00015,000--
Gross Interest Expense 17,00023,00015,000--
Interest Capitalized -----
Pretax Income (28.88M)(43.44M)(46.96M)(3.58M)(7.71M)
Income Tax 29,000103,000638,000--
Income Tax - Current Domestic --638,000--
Income Tax - Current Foreign -----
Income Tax - Deferred Domestic -----
Income Tax - Deferred Foreign -----
Income Tax Credits -----
Equity in Affiliates -----
Other After Tax Income (Expense) -----
Consolidated Net Income (28.91M)(43.54M)(47.6M)(3.58M)(7.71M)
Minority Interest Expense -----
Net Income (28.91M)(43.54M)(47.6M)(3.58M)(7.71M)
Extraordinaries & Discontinued Operations -----
Extra Items & Gain/Loss Sale Of Assets -----
Cumulative Effect - Accounting Chg -----
Discontinued Operations -----
Net Income After Extraordinaries (28.91M)(43.54M)(47.6M)(3.58M)(7.71M)
Preferred Dividends -----
Net Income Available to Common (28.91M)(43.54M)(47.6M)(3.58M)(7.71M)
EPS (Basic) (130.96)(111.67)(112.74)(7.37)(1.89)
Basic Shares Outstanding 220,750389,913422,200486,1684.09M
EPS (Diluted) (130.96)(111.67)(112.74)(7.37)(1.89)
Diluted Shares Outstanding 220,750389,913422,200486,1684.09M
EBITDA (28.61M)(42.47M)(34.09M)(3.6M)(7.73M)
Copyright 2022 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Link to MarketWatch's Slice.